$22.5 Million is the total value of Burren Capital Advisors Ltd's 9 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 94.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CNL | Sell | CLECO CORP NEW | $5,247,000 | -25.2% | 98,561 | -24.3% | 23.32% | +70.0% |
| ISSI | Sell | INTEGRATED SILICON SOLUTION | $3,490,000 | -5.5% | 162,400 | -2.6% | 15.51% | +114.7% |
| CYT | New | CYTEC INDS INC | $3,434,000 | – | 46,500 | +100.0% | 15.26% | – |
| ALTR | ALTERA CORP | $3,423,000 | -2.2% | 68,347 | 0.0% | 15.22% | +122.3% | |
| OMC | New | OMNICOM GROUP INC | $3,404,000 | – | 103,500 | +100.0% | 15.13% | – |
| BRCM | Buy | BROADCOM CORPcl a | $2,932,000 | +28.7% | 57,000 | +28.8% | 13.03% | +192.4% |
| HCC | New | HCC INS HLDGS INC | $325,000 | – | 4,200 | +100.0% | 1.44% | – |
| ATML | ATMEL CORP | $141,000 | -18.5% | 17,525 | 0.0% | 0.63% | +85.5% | |
| MRVL | New | MARVELL TECHNOLOGY GROUP LTDord | $101,000 | – | 11,110 | +100.0% | 0.45% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS | $0 | – | -13,900 | -100.0% | -0.41% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -2,220 | -100.0% | -1.32% | – |
| KYTH | Exit | KYTHERA BIOPHARMACEUTICALS I | $0 | – | -18,840 | -100.0% | -2.78% | – |
| WEN | Exit | WENDYS CO | $0 | – | -176,543 | -100.0% | -3.90% | – |
| A309PS | Exit | DIRECTV | $0 | – | -25,038 | -100.0% | -4.54% | – |
| FDO | Exit | FAMILY DLR STORES INC | $0 | – | -30,600 | -100.0% | -4.72% | – |
| YHOO | Exit | YAHOO INC | $0 | – | -65,650 | -100.0% | -5.04% | – |
| INFA | Exit | INFORMATICA CORP | $0 | – | -71,000 | -100.0% | -6.73% | – |
| EXL | Exit | EXCEL TR INC | $0 | – | -218,900 | -100.0% | -6.75% | – |
| IGTE | Exit | IGATE CORP | $0 | – | -74,300 | -100.0% | -6.93% | – |
| ADVS | Exit | ADVENT SOFTWARE INC | $0 | – | -81,000 | -100.0% | -7.01% | – |
| PPO | Exit | POLYPORE INTL INC | $0 | – | -60,200 | -100.0% | -7.05% | – |
| HSP | Exit | HOSPIRA INC | $0 | – | -59,000 | -100.0% | -10.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DELL TECHNOLOGIES INC | 9 | Q3 2018 | 39.0% |
| NXSTAGE MEDICAL INC | 5 | Q3 2018 | 9.1% |
| BRISTOL-MYERS SQUIBB CO | 4 | Q3 2020 | 100.0% |
| ALLERGAN PLC | 4 | Q1 2020 | 66.4% |
| FAMILY DLR STORES INC | 4 | Q2 2015 | 18.0% |
| TIME WARNER CABLE INC | 4 | Q1 2015 | 10.1% |
| RIVERBED TECHNOLOGY INC | 4 | Q4 2014 | 7.1% |
| WILLIS TOWERS WATSON PLC LTD | 3 | Q2 2021 | 100.0% |
| NXP SEMICONDUCTORS N V | 3 | Q3 2018 | 56.9% |
| CELGENE CORP | 3 | Q3 2019 | 38.2% |
View Burren Capital Advisors Ltd's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
View Burren Capital Advisors Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.